Top 50 Dna Data Storage in Europe

This company develops IT-friendly DNA Data Storage appliances engineered for data center environments. Their modular architecture combines biosecure DNA media with industrialized end-to-end processes to create a new storage tier optimized for density and longevity. The solution offers ultra-low energy consumption at rest and high data retention for long-term archival and high-security data preservation.

The startup operates a personal health and genomic data-sharing platform that connects users with researchers, enabling participation in studies on common and rare diseases. By allowing individuals to control their data and opt into research, the platform facilitates the collection of dynamic health and genetic datasets for personalized medicine.

Abrinca offers Arx, a web‑based platform that centralizes microbial genome storage, annotation, and comparative analysis, allowing users to upload FASTA or GenBank files and run tools such as pathway visualization, BLAST, phylogenetic tree construction, and gene‑trait matching without coding. The system manages metadata, permissions, and real‑time visualizations, supporting secure sharing and API integration for bioinformaticians, strain managers, and laboratory biologists.

Abrinca offers Arx, a web‑based platform that centralizes microbial genome storage, annotation, and comparative analysis, allowing users to upload FASTA or GenBank files and run tools such as pathway visualization, BLAST, phylogenetic tree construction, and gene‑trait matching without coding. The system manages metadata, permissions, and real‑time visualizations, supporting secure sharing and API integration for bioinformaticians, strain managers, and laboratory biologists.

TrueYouOmics utilizes DNA, RNA, and protein analyses, combined with AI-driven algorithms, to extract up to 3 billion datapoints from blood samples for personalized health risk assessments. The platform provides users with specific disease risk evaluations and tailored prevention plans, empowering them to make informed health decisions.

DnaNudge utilizes DNA analysis and lifestyle data to provide personalized nutritional guidance, helping consumers make healthier food choices based on their genetic predispositions to conditions like obesity and diabetes. The company also offers a rapid, lab-free CovidNudge RT-PCR test that accurately detects COVID-19 and other viruses in under an hour, facilitating timely diagnosis without laboratory dependency.

Nygen Analytics offers a cloud-based platform for the analysis of single-cell genomic data, utilizing bioinformatics techniques to enable researchers to visualize and interpret complex datasets without requiring coding skills. The platform addresses the challenges of data complexity and collaboration in single-cell studies, facilitating efficient data management and accelerating research insights.

Level Zero Health offers a skin‑adhesive wearable patch that continuously measures cortisol, progesterone, estrogen, and testosterone in interstitial fluid using DNA‑aptamer sensors, delivering hormone data with 98 % accuracy comparable to blood tests. The device streams real‑time results to a cloud platform, enabling fertility clinics, IVF programs, and endocrinology practices to remotely monitor patients and adjust hormone therapies promptly.

Evonetix is developing a desktop platform that synthesizes gene-length DNA with high accuracy and scalability using a novel approach to DNA synthesis. This technology provides researchers with rapid access to precise genetic material, addressing the limitations of current gene synthesis methods that hinder innovation in healthcare and biotechnology.

SwissDeCode provides rapid, on-site DNA testing kits for food manufacturers to detect contaminants and authenticate products, delivering results in under an hour. This technology enables companies to ensure food safety and compliance without the need for external laboratories, enhancing trust in the food supply chain.

Heidelberg Epignostix develops precision cancer diagnostics through DNA methylation profiling and machine learning algorithms for accurate tumor classification. This technology enhances diagnostic accuracy, enabling healthcare providers to make informed decisions regarding cancer treatment and management.

Watershed provides a platform for biological data analysis that integrates secure data management, customizable workflows, and supercomputing resources to enable rapid, large-scale analyses across various omics disciplines. By offering a dedicated bioinformatics team and ready-to-use AI tools, Watershed enhances productivity and collaboration for researchers facing the challenges of complex data interpretation.

Wobble Genomics develops advanced computational tools for analyzing complex genomic datasets. The platform provides researchers with high-throughput sequence alignment and variant calling capabilities. This accelerates discovery in areas like personalized medicine and disease mechanism identification.

Twelve Bio develops CRISPR-Cas12a diagnostic technology that enables precise detection and modification of DNA sequences. This technology addresses the need for accurate genetic diagnostics and targeted gene editing to treat genetic disorders and diseases.

Anjarium Biosciences develops synthetic, enzymatically produced linear double-stranded DNA with customizable hairpin-ended structures to enhance the production of gene therapies. Their technology addresses the challenges of traditional plasmid DNA by providing faster production times, higher purity, and scalable solutions for various therapeutic applications.

Code Biotherapeutics is developing a multivalent synthetic DNA delivery platform, 3DNA®, to enhance the precision and bioavailability of non-viral gene therapies for life-threatening diseases. The company focuses on overcoming challenges such as dose-related toxicity and off-target effects, with a primary research emphasis on Duchenne Muscular Dystrophy.

Camena Bioscience develops the gSynth® platform, a TdT-free enzymatic DNA synthesis technology that enables the high-throughput production of synthetic genes of any sequence, length, and complexity. This technology addresses the limitations of traditional DNA synthesis methods, which struggle to produce long, accurate synthetic DNA at scale, thereby facilitating advancements in personalized mRNA vaccines, cell and gene therapies, and CRISPR applications.

DNA Payments provides a range of payment solutions, including mobile and countertop card machines, online payment gateways, and ePOS systems, enabling businesses to accept and manage transactions across multiple channels. The platform offers real-time data insights and custom branding options, ensuring businesses maintain control over their payment processes while minimizing transaction fees.

This startup develops DNA technology tailored for synthetic biology applications, providing high-throughput libraries and custom DNA sequences for genome construction and data storage. Their services enable researchers and companies to efficiently create and manipulate DNA without facing economic or time constraints.

Haelixa utilizes patented DNA technology to mark and trace raw materials throughout the supply chain, ensuring product authenticity and compliance with due diligence regulations. This solution addresses the lack of transparency in supply chains, mitigating risks associated with material substitutions, counterfeits, and regulatory non-compliance.

Ontologic provides a Data Platform as a Service specifically designed for early-stage biotech companies transitioning research into business. This platform offers secure, out-of-the-box infrastructure enabling bioinformaticians and data scientists to rapidly generate and utilize code and data assets. The service allows scientific teams to focus on innovation by managing computational infrastructure, optimizing resource costs, and facilitating collaboration.

The startup operates a synthetic biology platform that designs and manufactures biomedicines by creating product-specific libraries of synthetic genetic parts. By utilizing bioinformatic analysis of genome-scale data, the company enables clients to engineer novel biomolecules tailored to specific therapeutic properties.

This startup offers next-day plasmid sequencing services with integrated bioinformatics analysis. Their platform provides high-throughput, quality, and cost-effective sequencing, supporting bioscience research globally.

Databiomix provides a cloud‑based, end‑to‑end bioinformatics service that automates high‑resolution microbiome profiling, complete bacterial genome assembly, and strain‑specific qPCR primer design. Their platforms deliver species‑level taxonomic insights, circularized genome annotations, and actionable biomarkers with fast turnaround and expert interpretation for clinical, biopharma, nutrition, food safety, and environmental applications.

Formical provides a cloud‑based platform for managing and analyzing biological data, enabling researchers to store, share, and process experimental results securely. The service includes tools for data organization, collaborative workflows, and integration with common bioinformatics pipelines.

Sherlock Biosciences develops CRISPR-based SHERLOCK™ and synthetic biology-based INSPECTR™ platforms for rapid and accurate DNA and RNA detection. Their technology provides accessible diagnostic tests at the point-of-need, enabling timely health decisions and improving global health equity.

Syngens AS has developed an AI-powered DNA Design Platform that enables precise and predictable DNA engineering for biomanufacturing applications. By optimizing gene expression and constructing novel biological pathways, the platform addresses the limitations of scalability and engineering precision in current biological methods, significantly reducing trial-and-error in experimental processes.

Econic Biosciences is developing a healthcare platform that targets extrachromosomal DNA (ecDNA), a significant driver of oncogenic gene amplification linked to treatment-resistant cancers. By utilizing artificial intelligence to identify and characterize ecDNA, the company aims to create targeted therapies that improve clinical outcomes for cancer patients.

Genomes.io provides a secure platform for individuals to upload their genomic data and retain ownership while enabling pharmaceutical and research organizations to access this data for studies through a blockchain-based consent system. This approach addresses the lack of transparency and equitable compensation in the genomics market, allowing users to monetize their DNA data while maintaining privacy and control.

Animol Discovery utilizes machine learning and DNA-encoded chemical libraries to develop targeted pharmaceuticals for veterinary patients. The startup addresses the lack of effective treatment options in veterinary medicine by accelerating the discovery of safer and more effective small molecules tailored to animal health needs.

Rightangled provides a platform for genetic and blood testing, connecting users with healthcare specialists to deliver personalized health insights and treatment plans. The service addresses the need for accessible and timely diagnostic testing, offering next-day delivery and same-day service in London to enhance patient care.

Rankfor.AI builds a structured Brand DNA knowledge graph from a brand's online content and evaluates how AI-driven channels perceive that brand against persona‑based buying profiles. The platform flags perception gaps and hallucinations, then delivers content recommendations and monitoring tools so marketing teams can align AI chatbot responses with their intended brand narrative.

ENPICOM provides a unified bioinformatics platform that integrates scalable data management, machine learning frameworks, and user-friendly analysis tools for lab and data scientists. This solution streamlines biologics discovery and engineering processes, enabling rapid data retrieval and model deployment while reducing reliance on specialized data science support.

RootPath Genomics develops a personalized T cell therapy platform utilizing molecular programming-based DNA fragment assembly technology to provide researchers with scalable access to long synthetic genes and their functional readouts. This approach addresses the need for efficient gene function interrogation in precision medicine, enabling faster and more accurate therapeutic development.

OmicsStudio is a cloud‑based platform that centralizes storage, processing, and visualization of multi‑omics datasets such as genomics, transcriptomics, and proteomics. It offers automated, containerized pipelines, interactive notebooks, and role‑based collaboration tools, enabling researchers and biotech teams to run scalable analyses without custom scripting and to share results securely.

Nanovery is developing liquid nanorobots that detect DNA and RNA biomarkers in liquid samples, providing precise quantification of nucleic acids. This technology addresses the challenges of traditional nucleic acid testing by simplifying workflows and reducing time and costs associated with biomarker analysis.

GenomSys provides a cloud-based genomic data analysis platform utilizing the ISO/IEC 23092 MPEG-G standard, enabling rapid processing and transmission of genomic files with up to 77% reduced file sizes. This technology facilitates faster time-to-market for genomic applications by streamlining workflows and enhancing data accessibility for healthcare professionals.

The startup develops DNA Damage Response (DDR) therapies that target aggressive cancers with high treatment resistance and poor survival rates. By enhancing the DNA repair mechanisms in cancer cells, the company aims to provide effective treatment options where conventional therapies have failed.

BioCaptiva develops msX™, a proprietary polymer technology that captures circulating free DNA (cfDNA) directly from biological fluids without additional reagents, enhancing sample yield and stability. This technology addresses the limitations of current liquid biopsy methods, enabling non-invasive cancer diagnosis and monitoring with improved sample quality and reduced risk of failure.

NAGENE specializes in the rapid synthesis of custom DNA sequences, utilizing a GMP-compliant, in-house process that ensures high-quality production within an average turnaround time of five days. This capability addresses the urgent need for reliable gene synthesis in pharmaceutical research and development, particularly for mRNA vaccines and cancer treatments.

Hyris provides a decentralized platform for nucleic acid testing, utilizing its proprietary Hyris System™ to enable real-time analysis of biological samples in various settings. This technology enhances diagnostic capabilities beyond traditional laboratories, facilitating access to genetic testing for healthcare, agrifood, and environmental applications.

Puro Analytics offers environmental DNA (eDNA) analysis to make biodiversity data visible and actionable for conservation and impact tracking. Their non-invasive service uses advanced sequencing and bioinformatics to detect species presence from various environmental samples, enabling organizations to establish baselines and monitor ecological changes.

The startup develops rapid diagnostics kits that utilize next-generation sequencing methods, including a 16S NGS library preparation kit for rRNA sequencing and quantification kits for DNA libraries and human gDNA. These tools enable scientists to accurately identify multiple bacterial species in mixed populations, facilitating faster disease detection across various platforms.

EcoPulse provides non-invasive biodiversity assessments by analyzing airborne environmental DNA (eDNA). Their platform captures and sequences eDNA from air samples to identify a wide range of species, delivering actionable insights for conservation and environmental management.

XGenomes develops DNA sequencing technologies that utilize optical super-resolution imaging and machine learning to monitor health, detect early disease signals, and track interventions throughout an individual's life. Their platform addresses high error rates and complex workflows in existing sequencing methods, providing a streamlined and cost-effective solution for continuous health monitoring.

The startup operates an information technology marketplace that enables businesses to compare and select software services tailored to their specific processes and industry needs. By providing digitization reports and budget estimations based on clients' Digital DNA, the platform simplifies and automates the software acquisition process.

Eligens provides a direct‑to‑consumer DNA testing service that ships saliva collection kits worldwide and returns high‑resolution genomic analysis using Illumina NovaSeq6000 sequencing. The platform delivers detailed ancestry reports—including ethnic composition across 500+ populations, ten‑generation family trees, and ancient migration routes—alongside health modules covering nutrigenomics, pharmacogenomics, disease risk, and trait insights, all accompanied by physician‑reviewed lifestyle recommendations. Results are securely stored in a personal online account for easy access and future reference.

Tailwind Biotech develops synthetic DNA design services utilizing artificial intelligence to enhance genetic engineering processes for biotechnology clients. The company designs optimized DNA sequences that maximize biologic manufacturing outputs while minimizing research and development costs. This approach delivers significantly improved gene expression and greater control over biomanufacturing outcomes.

This startup provides an AI-powered platform that analyzes an individual's DNA to offer personalized recommendations for diet, fitness, and supplements. It aims to make genetic-based healthy lifestyle planning accessible and affordable for consumers.

The startup offers a decentralized storage marketplace that enables clients to build and integrate services using APIs while ensuring compliance with data privacy regulations. This platform addresses the need for secure and private data management in the evolving landscape of Web 3.0.